Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma
Multiple myeloma (MM) is the second most common haematological malignancy and is an incurable disease of neoplastic plasma cells (PC). Newly diagnosed MM patients currently undergo lengthy genetic testing to match chromosomal mutations with the most potent drug/s to decelerate disease progression. W...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2022-03-01
|
| シリーズ: | Molecular Oncology |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/1878-0261.13055 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|